Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Sleep quality in bipolar disorder: A comparative study of treatment with lithium and valproic acid
Hasan Gokcay1, Uğur Takım2, Tarık Sağlam3
1Department of Psychiatry, University of Health Sciences, Sarkisla State Hospital, Sivas 58400, Türkiye.
Background:
Sleep disturbances are a prominent feature of bipolar disorder (BD) and often persist even in remission, thereby contributing to poor clinical outcomes. Despite the widespread use of lithium and valproic acid as mood stabilizers, their effects on sleep quality have not been examined in adequate detail.
Aim:
To evaluate and compare the effects of lithium and valproic acid on sleep quality in BD patients under remission.
Methods:
A total of 130 patients meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for BD in remission were included in this cross-sectional study. The participants were receiving either lithium (n = 78), or valproic acid (n = 52), for a minimum of six months either alone or in combination with antipsychotics. Sleep quality was measured using the Pittsburgh Sleep Quality Index (PSQI). Comparative analyses between the lithium and valproic acid groups were conducted using independent t-tests, χ 2 tests, and ANCOVA, adjusting for key variables such as age, sex, and body mass index.
Results:
Both groups demonstrated poor sleep quality, with the mean PSQI scores above the clinical threshold of 5. Patients in the lithium group exhibited significantly better habitual sleep efficiency (lithium: 0.47 ± 0.65, valproic acid: 0.78 ± 0.87, P = 0.009) and fewer sleep disturbances (lithium: 1.26 ± 0.57, valproic acid: 1.61 ± 0.84, P = 0.005). Other sleep parameters, including total sleep duration (P = 0.082) and sleep latency (P = 0.625), did not differ significantly.
Conclusion:
Patients in the lithium group showed significantly better habitual sleep efficiency and fewer sleep disturbances compared to those receiving valproic acid, although other sleep parameters did not differ. These findings suggest a potential advantage of lithium in certain aspects of sleep quality in BD patients under remission. Future studies using objective sleep measures and longitudinal designs are warranted to confirm these findings.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Bipolar Disorder
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
REM Sleep Behavior Disorder
RBD is significantly associated with...

